Our Expertise

Fred Hutchinson Cancer Research Center is one of Seattle Cancer Care Alliance's three parent institutions and the pioneer behind the use of bone-marrow transplantation as a treatment for leukemia over 40 years ago. Since then thousands of patients have come here from around the world to receive this life-saving treatment.

The Hutchinson Center Transplant Program at SCCA was ranked first in outcomes in a four-year study by the National Marrow Donor Program (NMDP) that measured one-year survival rates of patients among 119 transplant centers in the United States ¹

To see why SCCA is the best place for your child to receive a bone-marrow transplant, watch this video. As a result of our doctors’ expertise as pioneers in the field:

• Our transplant results are exceptional.
• We treat high-risk patients.
• We offer the latest therapies.
• We have a unique long-term follow-up program.

You may also want to read about our Pediatric Bone-Marrow Transplant Survival Rates.

You want the best for your child, and so do we. At SCCA, your child will receive excellent, world-class medical care in an environment designed to support your child and your entire family.

¹Final Report of Center-Specific Survival Rates in NMDP Facilitated Transplants Occurring Between January 1, 2002 through December 31, 2006. Note that the centers in this study (below) are anonymously identified and that Seattle Cancer Care Alliance is center #7205 as listed on page 9 of the report. SCCA, along with one other unidentified center, are the only two centers that ranked as “over-performing” in one-year survival rates of patients receiving a stem-cell transplant. For more information about NMDP visit www.marrow.org. SCCA is a member of the NMDP network.

10-21-2008

Final Report of Center-Specific Survival Rates in NMDP Facilitated Transplants (338kb)